ACETYLSALICYLIC ACID CAFFEINE & 8MG COD PHOS TABLET Canada - English - Health Canada

acetylsalicylic acid caffeine & 8mg cod phos tablet

stanley pharmaceuticals, a division of vita health products inc. - codeine (codeine phosphate); acetylsalicylic acid; caffeine - tablet - 8mg; 375mg; 15mg - codeine (codeine phosphate) 8mg; acetylsalicylic acid 375mg; caffeine 15mg - salicylates

C T ACETYLSALICYLIC ACID CODEINE AND CAF TAB TABLET Canada - English - Health Canada

c t acetylsalicylic acid codeine and caf tab tablet

pharmavite laboratories (1987) inc. - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 325mg; 16mg; 8mg - acetylsalicylic acid 325mg; caffeine 16mg; codeine phosphate 8mg - salicylates

ACETYLSALICYLIC ACID, CAFFEINE AND 8 MG CODEINE PHOSPHATE TABLET Canada - English - Health Canada

acetylsalicylic acid, caffeine and 8 mg codeine phosphate tablet

cellchem pharmaceuticals inc. - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 375mg; 15mg; 8mg - acetylsalicylic acid 375mg; caffeine 15mg; codeine phosphate 8mg - opiate agonists

ACETYLSALICYLIC ACID, CAFFEINE & 8 MG CODEINE PHOSPHATE TABLETS Canada - English - Health Canada

acetylsalicylic acid, caffeine & 8 mg codeine phosphate tablets

jamp pharma corporation - acetylsalicylic acid; caffeine; codeine phosphate - tablet - 375mg; 15mg; 8mg - acetylsalicylic acid 375mg; caffeine 15mg; codeine phosphate 8mg - opiate agonists

DOLVIRAN Tablet Kenya - English - Pharmacy and Poisons Board

dolviran tablet

bayer pharma ag bayer pharma ag 13342 berlin germany - acetylsalicylic acid codeine phosphate… - tablet - acetylsalicylic acid codeine phosphate… - opioid analgesics: natural opium alkaloids

CORYPHEN 325 CODEINE 30 TAB TABLET Canada - English - Health Canada

coryphen 325 codeine 30 tab tablet

rougier pharma division of ratiopharm inc - acetylsalicylic acid; codeine phosphate - tablet - 325mg; 30mg - acetylsalicylic acid 325mg; codeine phosphate 30mg - salicylates

CORYPHEN 650 CODEINE 30 TAB TABLET Canada - English - Health Canada

coryphen 650 codeine 30 tab tablet

rougier pharma division of ratiopharm inc - acetylsalicylic acid; codeine phosphate - tablet - 650mg; 30mg - acetylsalicylic acid 650mg; codeine phosphate 30mg - salicylates

CODEINE SULFATE tablet United States - English - NLM (National Library of Medicine)

codeine sulfate tablet

lannett company, inc. - codeine sulfate (unii: 11qv9bs0cb) (codeine anhydrous - unii:ux6owy2v7j) - codeine sulfate 15 mg - codeine sulfate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [ s ee warnings and precautions ( 5.1 ) ] , reserve codeine sulfate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: - have not been tolerated, or are not expected to be tolerated. have not been tolerated, or are not expected to be tolerated. - have not provided adequate analgesia, or are not expected to provide adequate analgesia. have not provided adequate analgesia, or are not expected to provide adequate analgesia. codeine sulfate tablets are contraindicated for: - all children younger than 12 years of age [see warnings and precautions ( 5.4 )] . - post-operative management in children younger than 18 years of age following tonsillect

CODEINE AND CHLORPHENIRAMINE MALEATE ER tablet, extended release United States - English - NLM (National Library of Medicine)

codeine and chlorpheniramine maleate er tablet, extended release

nexgen pharma, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - codeine phosphate 54.3 mg - codeine phosphate and chlorpheniramine maleate is indicated for the relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults 18 years of age and older. important limitations of use not indicated for pediatric patients under 18 years of age [see use in special population (8.4)] patients with known hypersensitivity to codeine, chlorpheniramine or any of the inactive ingredients of codeine phosphate and chlorpheniramine maleate. persons known to be hypersensitive to certain other opioids may exhibit cross-sensitivity to codeine. teratogenic effects pregnancy category c there are no adequate and well-controlled studies of codeine phosphate and chlorpheniramine maleate in pregnant women. reproductive toxicity studies have not been conducted with codeine phosphate and chlorpheniramine maleate; however, studies are available with individual active ingredients or related active ingredients. because animal reproduction studies are not always predictive of human response, co